HISTORY

The absence of molecular amplification in proteomics and metabolomics means that researchers rely heavily on sensitive detection of a biomarker during analytical separation. In recent years, LC performance has been the limiting factor in such experiments as the incremental improvement of conventional columns stalls. 

Based on top-level academic research demonstrating the effects of order and disorder in particulate-based separation systems, PharmaFluidics introduces a new generation of chromatography columns. The company’s know-how is the design and manufacturing of miniaturized separation columns by silicon micromachining. The perfect order in the stationary phase leads to unique benefits in terms of performance, reproducibility and robustness.

PharmaFluidics was founded in 2010 as a spin-off from the University of Brussels (VUB). The first external funding was raised in 2014, followed by additional capital increases in 2016 and 2018 from experienced venture capital investors. Sales of the µPACTM columns were launched in 2017, and the company continues to build its portfolio based on the pillar array technology.  

With offices in Ghent, PharmaFluidics is located at the heart of the Flanders life sciences valley. This biotech hub features a mix of world-renowned universities, knowledge centers and biotech companies, giving the company direct access to talent, financing opportunities and a network of thriving companies. 

JOIN THE PHARMAFLUIDICS TEAM

We’re looking for new colleagues to join our team!

Junior Account Manager DACH region

In line with its steep growth ambitions PharmaFluidics seeks to extend its team with a Junior Account Manager in the DACH region.

The Junior Account Manager will:

  • Build, develop and maintain multi-level contacts within selected accounts;
  • Prepare and negotiate technical-commercial proposals, contracts and orders;
  • Demonstrate commercial traction for PharmaFluidics’ innovative range of μPAC™ microchip based chromatography products, at analytical research groups of major accounts in biotech, pharma, academic centers and related industries.

BOARD OF DIRECTORS

Michel Allé_Independent Executive Chairman_PharmaFluidics

Michel Allé

Independent Executive Chairman

Marie Bouillez

Director, Theodorus

Rudi Mariën

Director, RMM

Annie Vereecken

Director, Heran
Fasha Mahjoor_PharmaFLuidics_

Fasha Mahjoor

Independent Director

Danny Gonnissen, PhD

Director, Qbic
Jeroen Van den Bossche_PharmaFluidics_Director PMV

Jeroen Van den Bossche

Director, PMV

Gert Desmet, PhD

Director, Co-founder

Johan Devenyns, PhD, MBA

Managing Director

ADVISORY BOARD & MANAGEMENT

Gert Desmet, PhD

Advisory Board Chair

Pat Sandra

Founder and owner of RIC Kortrijk

Jean-Pierre Chervet

Founder and CEO of LC Packings, Sold to Dionex Company (later Thermo-Fisher)
Matthias Mann

Matthias Mann

Professor at the Max Planck Institute (Germany) and the University of Copenhagen (Denmark)

Gerard Rozing

Over 23 years at Agilent

Johan Devenyns, PhD, MBA

Managing Director

Paul Jacobs, PhD

COO, Co-founder
Gilles Jaouen_Senior Key Account Manager France -South Europe_PharmaFluidics

Gilles Jaouen, MBA

VP Marketing & Sales
Bart Catrysse_VP Finance_PharmaFluidics

Bart Catrysse, MBA

VP Finance
X